• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气道清除治疗对成人囊性纤维化患者黏液清除功能的影响:一项随机对照试验。

Effect of airway clearance therapies on mucociliary clearance in adults with cystic fibrosis: A randomized controlled trial.

机构信息

Department of Medicine, Oregon Health and Science University (OHSU), Portland, Oregon, United States of America.

Department of Medicine, University of North Carolina (UNC), Chapel Hill, North Carolina, United States of America.

出版信息

PLoS One. 2022 May 20;17(5):e0268622. doi: 10.1371/journal.pone.0268622. eCollection 2022.

DOI:10.1371/journal.pone.0268622
PMID:35594286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9122229/
Abstract

BACKGROUND

Cystic fibrosis (CF) is an inherited disorder causing impaired mucociliary clearance within the respiratory tract, and is associated with bronchiectasis, chronic respiratory infections, and early death. Airway clearance therapies have long been a cornerstone of management of individuals with CF, although evidence supporting their use is lacking. We designed a randomized controlled trial to quantitatively compare the effects of different forms of airway clearance on mucociliary clearance.

METHODS

Three different physiotherapy methods to augment cough-clearance were studied in addition to cough-clearance alone: high-frequency chest-wall oscillating vest, oscillatory positive expiratory pressure, and whole-body vibration. We used gamma scintigraphy after inhalation of radiolabeled particles to quantify mucus clearance before, during, and after physiotherapy. As secondary endpoints, we measured concentrations of small molecules in exhaled breath that may impact mucus clearance.

RESULTS

Ten subjects were enrolled and completed study procedures. No differences were identified between any method of airway clearance, including cough clearance alone. We did identify changes in certain small molecule concentrations in exhaled breath following airway clearance.

CONCLUSIONS

Due to the limitations of this study, we do not believe the negative results suggest a change in clinical practice with regard to airway clearance. Findings pertaining to small molecules in exhaled breath may serve as future opportunities for study.

摘要

背景

囊性纤维化(CF)是一种遗传性疾病,导致呼吸道内的黏液纤毛清除功能受损,与支气管扩张、慢性呼吸道感染和早逝有关。气道清除疗法一直是 CF 患者管理的基石,尽管缺乏支持其使用的证据。我们设计了一项随机对照试验,定量比较不同形式的气道清除对黏液清除的影响。

方法

除单独咳嗽清除外,还研究了三种不同的物理治疗方法来增强咳嗽清除:高频胸壁振荡背心、振荡性呼气正压和全身振动。我们在吸入放射性标记颗粒后使用伽马闪烁法来量化物理治疗前后的黏液清除。作为次要终点,我们测量了呼气中小分子的浓度,这些小分子可能会影响黏液清除。

结果

10 名受试者入组并完成了研究程序。任何气道清除方法(包括单独咳嗽清除)之间均未发现差异。我们确实在气道清除后发现呼出气体中某些小分子浓度发生了变化。

结论

由于本研究的局限性,我们认为阴性结果并不意味着气道清除方面的临床实践会发生改变。呼出气体中小分子的发现可能为未来的研究提供机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/9122229/648585d034ea/pone.0268622.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/9122229/2692ac877d27/pone.0268622.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/9122229/4652beeada53/pone.0268622.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/9122229/648585d034ea/pone.0268622.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/9122229/2692ac877d27/pone.0268622.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/9122229/4652beeada53/pone.0268622.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1264/9122229/648585d034ea/pone.0268622.g003.jpg

相似文献

1
Effect of airway clearance therapies on mucociliary clearance in adults with cystic fibrosis: A randomized controlled trial.气道清除治疗对成人囊性纤维化患者黏液清除功能的影响:一项随机对照试验。
PLoS One. 2022 May 20;17(5):e0268622. doi: 10.1371/journal.pone.0268622. eCollection 2022.
2
Oscillating devices for airway clearance in people with cystic fibrosis.用于囊性纤维化患者气道清理的振荡装置。
Cochrane Database Syst Rev. 2020 Apr 30;4(4):CD006842. doi: 10.1002/14651858.CD006842.pub5.
3
Oscillating devices for airway clearance in people with cystic fibrosis.用于囊性纤维化患者气道清理的振荡装置。
Cochrane Database Syst Rev. 2017 May 4;5(5):CD006842. doi: 10.1002/14651858.CD006842.pub4.
4
Oscillating devices for airway clearance in people with cystic fibrosis.用于囊性纤维化患者气道清除的振荡装置。
Cochrane Database Syst Rev. 2014 Jul 20(7):CD006842. doi: 10.1002/14651858.CD006842.pub3.
5
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.用于囊性纤维化患者气道清理的呼气末正压物理治疗
Cochrane Database Syst Rev. 2019 Nov 27;2019(11):CD003147. doi: 10.1002/14651858.CD003147.pub5.
6
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.囊性纤维化患者气道清理的呼气正压物理治疗
Cochrane Database Syst Rev. 2015 Jun 17(6):CD003147. doi: 10.1002/14651858.CD003147.pub4.
7
Airway clearance devices for cystic fibrosis: an evidence-based analysis.用于囊性纤维化的气道清理装置:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(26):1-50. Epub 2009 Nov 1.
8
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.囊性纤维化的增效剂(针对III类和IV类突变的特定疗法)。
Cochrane Database Syst Rev. 2019 Jan 7;1(1):CD009841. doi: 10.1002/14651858.CD009841.pub3.
9
Oscillating devices for airway clearance in people with cystic fibrosis.用于囊性纤维化患者气道清理的振荡装置。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD006842. doi: 10.1002/14651858.CD006842.pub2.
10
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.用于囊性纤维化患者气道廓清的呼气正压物理治疗
Cochrane Database Syst Rev. 2006 Apr 19(2):CD003147. doi: 10.1002/14651858.CD003147.pub3.

引用本文的文献

1
detection of pulmonary mucociliary clearance: present challenges and future directions.肺黏液清除功能的检测:当前的挑战与未来方向。
Eur Respir Rev. 2024 Sep 18;33(173). doi: 10.1183/16000617.0073-2024. Print 2024 Jul.
2
Comparison of a novel potentiator of CFTR channel activity to ivacaftor in ameliorating mucostasis caused by cigarette smoke in primary human bronchial airway epithelial cells.比较一种新型 CFTR 通道激活剂与 ivacaftor 对香烟烟雾引起的原代人支气管气道上皮细胞粘液阻塞的改善作用。
Respir Res. 2024 Jul 10;25(1):269. doi: 10.1186/s12931-024-02889-w.

本文引用的文献

1
Oscillating devices for airway clearance in people with cystic fibrosis.用于囊性纤维化患者气道清理的振荡装置。
Cochrane Database Syst Rev. 2020 Apr 30;4(4):CD006842. doi: 10.1002/14651858.CD006842.pub5.
2
Whole body periodic acceleration in normal and reduced mucociliary clearance of conscious sheep.清醒绵羊正常和黏液纤毛清除功能降低时的全身周期性加速。
PLoS One. 2019 Nov 7;14(11):e0224764. doi: 10.1371/journal.pone.0224764. eCollection 2019.
3
Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.
在囊性纤维化患儿中,肺部黏液堆积先于结构改变和感染。
Sci Transl Med. 2019 Apr 3;11(486). doi: 10.1126/scitranslmed.aav3488.
4
Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis.高渗盐水对囊性纤维化成人的黏液清除有持久作用。
J Cyst Fibros. 2018 Sep;17(5):650-656. doi: 10.1016/j.jcf.2018.01.001. Epub 2018 Jan 20.
5
Cystic fibrosis.囊性纤维化。
Lancet. 2016 Nov 19;388(10059):2519-2531. doi: 10.1016/S0140-6736(16)00576-6. Epub 2016 Apr 29.
6
Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis.依伐卡托治疗囊性纤维化患者呼气一氧化氮的效果。
J Cyst Fibros. 2015 Nov;14(6):727-32. doi: 10.1016/j.jcf.2015.07.001. Epub 2015 Jul 11.
7
Duration of action of hypertonic saline on mucociliary clearance in the normal lung.高渗盐水对正常肺脏黏液纤毛清除功能的作用持续时间。
J Appl Physiol (1985). 2015 Jun 15;118(12):1483-90. doi: 10.1152/japplphysiol.00404.2014. Epub 2015 Apr 24.
8
Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.囊性纤维化跨膜传导调节因子增强剂依伐卡托在G551D介导的囊性纤维化中的临床机制
Am J Respir Crit Care Med. 2014 Jul 15;190(2):175-84. doi: 10.1164/rccm.201404-0703OC.
9
Multisite comparison of mucociliary and cough clearance measures using standardized methods.使用标准化方法进行黏液纤毛清除和咳嗽清除措施的多中心比较。
J Aerosol Med Pulm Drug Deliv. 2013 Jun;26(3):157-64. doi: 10.1089/jamp.2011.0909. Epub 2013 Mar 21.
10
Exhaled breath condensate adenosine tracks lung function changes in cystic fibrosis.呼出气冷凝液中的腺苷可追踪囊性纤维化患者的肺功能变化。
Am J Physiol Lung Cell Mol Physiol. 2013 Apr 1;304(7):L504-9. doi: 10.1152/ajplung.00344.2012. Epub 2013 Jan 25.